The efficacy of a single-session pro-yellow laser in the treatment of facial telangiectasia

Basit Öğe Kaydı
dc.authoridAltunisik, Nihal/0000-0001-6844-1097
dc.authoridTürkmen, Dursun/0000-0001-9076-4669;
dc.authorwosidAltunisik, Nihal/ABG-8567-2020
dc.authorwosidTürkmen, Dursun/ABG-3801-2020
dc.authorwosidSener, Serpil/ABI-6229-2020
dc.contributor.authorTurkmen, Dursun
dc.contributor.authorAltunisik, Nihal
dc.contributor.authorSener, Serpil
dc.date.accessioned2024-08-04T20:47:27Z
dc.date.available2024-08-04T20:47:27Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractFacial telangiectasia (FT) is a condition in which small dilated vessels visibly protrude on the surface of the skin. The aim of this study was to evaluate the efficacy and safety of a single-session pro-yellow laser in the treatment of FT and spider angioma (SA) to compare it with a limited number of studies conducted on this subject. In this pilot study, we reviewed 41 patients who admitted to our dermatology clinic with FT and SA and were treated by using pro-yellow laser. The efficacy of the treatment was evaluated using the recorded clinical information and digital camera images. The improvement was graded as complete (90-100%), very good (75-89%), good (50-74%), moderate (25-49%), and weak (< 25%). Of the 41 patients included in the study, 37 (90.2%) had FT and four (9.8%) had SA. Twenty-two patients were female and 19 were male. Pro-yellow laser therapy was generally well tolerated by patients, and minimal pain occurred during the application. In 1-month follow-up, good, very good, or complete recovery was achieved in 51.4% of the FT patients. The new pro-yellow laser only has a yellow light wavelength. Its unique wavelength at 577-nm yellow light is ideal for vascular lesions. In this study, 51.4% of the patients with FT achieved good, very good, or complete improvement after a single session of 577-nm pro-yellow laser, and complete improvement was achieved in all the four patients with SA.en_US
dc.identifier.doi10.1007/s10103-020-03082-3
dc.identifier.endpage406en_US
dc.identifier.issn0268-8921
dc.identifier.issn1435-604X
dc.identifier.issue2en_US
dc.identifier.pmid32592131en_US
dc.identifier.scopus2-s2.0-85087301419en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage401en_US
dc.identifier.urihttps://doi.org/10.1007/s10103-020-03082-3
dc.identifier.urihttps://hdl.handle.net/11616/99384
dc.identifier.volume36en_US
dc.identifier.wosWOS:000543602100001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer London Ltden_US
dc.relation.ispartofLasers in Medical Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFacial telangiectasiaen_US
dc.subjectLaser therapyen_US
dc.subjectPro-yellow laseren_US
dc.subjectSpider angiomaen_US
dc.subject577 nmen_US
dc.titleThe efficacy of a single-session pro-yellow laser in the treatment of facial telangiectasiaen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu